Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis
暂无分享,去创建一个
D E Low | D. Low | B. Kreiswirth | M. Louie | A. Simor | A E Simor | B Kreiswirth | M Louie | S Szeto | M Patel | M. Patel | S. Szeto
[1] A. Kaplan,et al. Recovery of resistant enterococci during vancomycin prophylaxis , 1988, Journal of clinical microbiology.
[2] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.
[3] L. Bougueleret,et al. High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes , 1979, Antimicrobial Agents and Chemotherapy.
[4] D E Low,et al. Comparison of the new MicroScan Pos MIC Type 6 panel and AMS-Vitek Gram Positive Susceptibility Card (GPS-TA) for detection of high-level aminoglycoside resistance in Enterococcus species , 1991, Journal of clinical microbiology.
[5] B. Murray. The life and times of the Enterococcus , 1990, Clinical Microbiology Reviews.
[6] G L Woods,et al. Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis , 1991, Journal of clinical microbiology.
[7] D E Low,et al. Evaluation of a commercial microtiter system (MicroScan) using both frozen and freeze-dried panels for detection of high-level aminoglycoside resistance in Enterococcus spp , 1990, Journal of clinical microbiology.
[8] M. Zervos,et al. Serious infection due to beta-lactamase-producing Streptococcus faecalis with high-level resistance to gentamicin. , 1988, The Journal of infectious diseases.
[9] M. Sande,et al. Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis. , 1979, The Journal of infectious diseases.
[10] R. Moellering,et al. Mechanism of Resistance to Antibiotic Synergism in Enterococci , 1971, Journal of bacteriology.
[11] R. Moellering,et al. The enterococcus: "putting the bug in our ears". , 1987, Annals of internal medicine.
[12] R. Jones,et al. Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations , 1987, Antimicrobial Agents and Chemotherapy.
[13] L. Verbist. In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci , 1987, Antimicrobial Agents and Chemotherapy.
[14] N Woodford,et al. Vancomycin-resistant enterococci , 1993, The Lancet.
[15] M. Zervos,et al. Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. , 1987, Annals of internal medicine.
[16] G. Eliopoulos,et al. In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic , 1985, Antimicrobial Agents and Chemotherapy.
[17] R. Facklam,et al. Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. , 1970, Antimicrobial agents and chemotherapy.
[18] R. Moellering,et al. Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. , 1971, The Journal of clinical investigation.
[19] B. Murray,et al. Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis. , 1983, The Journal of clinical investigation.
[20] M. Collins,et al. Identification of Enterococcus species isolated from human infections by a conventional test scheme , 1989, Journal of clinical microbiology.
[21] M. Wendeler,et al. High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. , 1989, Annals of internal medicine.
[22] M. Ferraro,et al. Detection of enterococcal high-level aminoglycoside resistance with MicroScan freeze-dried panels containing newly modified medium and Vitek Gram-Positive Susceptibility cards , 1991, Journal of clinical microbiology.
[23] R. Facklam. Recognition of group D streptococcal species of human origin by biochemical and physiological tests. , 1972, Applied microbiology.
[24] G. Eliopoulos,et al. High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium , 1988, Antimicrobial Agents and Chemotherapy.
[25] W. J. Tuddenham,et al. Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? , 1989, Journal of clinical microbiology.
[26] B. Murray,et al. High-level resistance to gentamicin in clinical isolates of enterococci. , 1983, The Journal of infectious diseases.
[27] J. Duval,et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. , 1988, The New England journal of medicine.